Updated March 23 at 12:28am
Life Sciences
78 results total, viewing 11 - 20
Dr. Barrett Bready is founder and CEO of Nabsys, a genomics firm. An adjunct professor at Brown University where he teaches biotechnology management, Bready also serves as a commissioner on the I-195 Redevelopment District Commission. Bready talked with Providence Business News about Nabsys’ evolution and goals for the future. more
(Updated 9:23 a.m. and 4:23 p.m.) The I-195 Redevelopment District Commission authorized a series of incentives Monday to attract Wexford Science & Technology LLC, as well as the Cambridge Innovation Center, to two prime parcels of the former highway land. more
(Updated, Dec. 19, 4:40 p.m.) EpiVax Inc. is part of a team that has been awarded a $1.87 million grant from Department of Defense’s Defense Threat Reduction Agency to develop an effective vaccine against a bacterium that leads to melioidosis, a tropical disease that is resistant to many antibiotics. more
Medley Genomics, which provides smart software solutions for optimizing effective individualized therapy for cancer patients, recently won the inaugural MassChallenge Bridge to Rhode Island Bootcamp, in which Rhode Island-based startups competed for a chance to participate in the MassChallenge accelerator. more
Two hundred and fifteen college graduates working in science, technology, engineering and mathematics fields were chosen as the recipients of R.I. Commerce Corp.’s first Wavemaker Fellowships, a tax credit to defray student loan repayment. more
(Updated, 6:15 p.m.) Ventas Inc., a real estate investment trust with more than 1,300 properties, has announced its intention to purchase substantially all of the assets of Wexford Science & Technology LLC. more
Lifespan today announced that it will unify its cancer care services and research across all of its hospitals and outpatient centers under a single entity, the Lifespan Cancer Institute. more
Lamya Karim, an assistant professor of bioengineering at the University of Massachusetts Dartmouth, has been awarded a $616,170 grant from the National Institutes of Health to study how Type 2 diabetes weakens bones and results in patients being at much greater risk for fractures. more
Could Providence be the next Cambridge, a city known as a biotechnology hub? Given recent economic-development activity, it would seem that this corner of the technology sector is on the verge of a takeoff. Since CV Properties LLC and … more
(Updated 11:28 a.m.) Gov. Gina M. Raimondo was high-spirited, as was the crowd of some 100 leaders from Rhode Island’s business, health care and academic sectors this morning, when she announced that Johnson & Johnson, one of the world’s most well-known and largest health care companies, will site a health technology center here. more
« Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 8 | Next »